Diarrhea from ipilimumab in melanoma.
Jonathan D
JD
Schwartz
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D019496:Cancer Vaccines / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003967:Diarrhea / Q000139:chemically induced / Q000276:immunology*; D006801:Humans; D000074324:Ipilimumab; D008545:Melanoma / Q000188:drug therapy* / Q000556:secondary / Q000628:therapy
D000911:Antibodies, Monoclonal; D019496:Cancer Vaccines; D000074324:Ipilimumab